1. Bisno, A. L., Dismukes, W. E., and Durack, D. T., Antimicrobial treatment of infective endocarditis due to viridans streptococci, and staphylococci.JAMA, 261, 1471–1477 (1987).
2. Burm, J. P., Choi, J. S., Jhee, S., and Gill, M. A., Population pharmacokinetics for gentamicin in American and Korean- American appendicitis patients using Nonparametric expected maximum algorithm.Yakhak Hoeji, 39, 103–112 (1995).
3. Choi, J. S., Moon, H. S., Choi, I., and Burm, J. P., Clinical pharmacokinetics of gentamicin in gastrointestnal surgical patients.Yakhak Hoeji, 40, 1–9 (1996).
4. Chrystn, H., Validation of the use of Bayesian analysis in the optimization of gentamicin therpy from the commencement of dosing.Drug Intell. Clin. Pharm., 22, 49–53 (1988).
5. Dahlgren, J. G., Anderson, E. T., and Hewitt, W. L., Gentamicin blood level: A guide to nephrotoxicity.Antimicrob. Agents Chemother., 8, 58–62 (1975).